Mazor Robotics Ltd – (NASDAQ:MZOR) was the recipient of a significant drop in short interest in the month of September. As of September 28th, there was short interest totalling 1,807,041 shares, a drop of 41.3% from the September 14th total of 3,079,746 shares. Based on an average daily trading volume, of 1,538,428 shares, the short-interest ratio is currently 1.2 days.
MZOR has been the topic of several research reports. Zacks Investment Research upgraded Mazor Robotics from a “sell” rating to a “hold” rating in a research note on Friday, September 28th. Needham & Company LLC restated a “sell” rating on shares of Mazor Robotics in a research note on Thursday, August 2nd. ValuEngine upgraded Mazor Robotics from a “hold” rating to a “buy” rating in a research note on Friday, September 7th. Finally, BidaskClub upgraded Mazor Robotics from a “sell” rating to a “hold” rating in a research note on Friday, July 6th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, two have given a buy rating and two have assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $61.08.
A number of institutional investors and hedge funds have recently bought and sold shares of the business. NEXT Financial Group Inc purchased a new position in Mazor Robotics in the third quarter valued at about $110,000. Sturgeon Ventures LLP grew its stake in Mazor Robotics by 25.1% in the second quarter. Sturgeon Ventures LLP now owns 68,948 shares of the medical instruments supplier’s stock valued at $3,817,000 after purchasing an additional 13,848 shares during the last quarter. Advisors Asset Management Inc. purchased a new stake in shares of Mazor Robotics during the second quarter worth about $451,000. Global X Management Co LLC grew its stake in shares of Mazor Robotics by 19.7% during the second quarter. Global X Management Co LLC now owns 506,196 shares of the medical instruments supplier’s stock worth $28,099,000 after acquiring an additional 83,387 shares during the last quarter. Finally, Carnegie Capital Asset Management LLC grew its stake in shares of Mazor Robotics by 7.8% during the second quarter. Carnegie Capital Asset Management LLC now owns 20,660 shares of the medical instruments supplier’s stock worth $950,000 after acquiring an additional 1,500 shares during the last quarter. Institutional investors own 23.98% of the company’s stock.
MZOR opened at $58.01 on Friday. Mazor Robotics has a 1 year low of $41.60 and a 1 year high of $76.56. The stock has a market capitalization of $1.54 billion, a price-to-earnings ratio of -116.02 and a beta of 1.43.
Mazor Robotics (NASDAQ:MZOR) last posted its earnings results on Thursday, August 2nd. The medical instruments supplier reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.13). Mazor Robotics had a negative net margin of 12.80% and a negative return on equity of 7.17%. The company had revenue of $13.20 million during the quarter, compared to analysts’ expectations of $17.02 million. During the same quarter last year, the firm earned ($0.05) EPS. Mazor Robotics’s revenue for the quarter was down 14.8% on a year-over-year basis. As a group, equities research analysts expect that Mazor Robotics will post -0.12 EPS for the current fiscal year.
Mazor Robotics Company Profile
Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures.
Featured Story: Stock Selection – What is cash flow?
Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.